Kids’ flu vax needs scrutiny

Australia suspended paediatric influenza vaccinations in 2010 as a result of high fevers and convulsions associated with Fluvax (CSL TIV). Following estimation that the risk of febrile convulsions in young children after vaccination with CSL TIV was 3—10 per 1000 children vaccinated in 2010, it is no longer registered for children under five in Australia, the US and UK.

Public health physician Dr Paul Effler and epidemiologist Professor Heath Kelly reviewed the history of the vaccine and found room for